Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

statutory medicines

- PMLiVE

Opdivo approved via UK’s early drug access scheme

Bristol-Myers Squibb’s immunotherapy the first lung cancer drug approved by EAMS

UK ramps up online access to GP services

Number of practices offering services like appointments via the internet tripled in first three months of 2015

- PMLiVE

George Freeman re-appointed as UK life science minister

Industry welcomes his continuation in this pharma-focused role

- PMLiVE

Prescribing costs jump in England

New report finds that asthma and diabetes drugs the most costly to the NHS

- PMLiVE

More money for the NHS – but is this the answer?

Politicians opening their pre-election cheque books can’t put the UK’s health service where it needs to be – but pharma could have a major role to play

- PMLiVE

The BMJ weighs in on Avastin/Lucentis debate

The UK’s leading medical journal says Avastin should be used for wet AMD to cut costs

NHS to expand video and email consultation pilots

Move is part of plans to increase patient access to GPs and pharmacists

- PMLiVE

Nurturing innovation in a tough environment

Much has been achieved in the UK in recent years, but the NHS still has a way to go

It’s time to get diabetes right

Patients should have access to the right treatment and care, at the right time, says the ABPI Pharmaceutical Diabetes Initiative 

- PMLiVE

Pricing pressures preventing UK access to MenB vaccine

GlaxoSmithKline’s Bexsero will need a dramatic price cut to gain NHS entry

UK flag

Pharmacists to help England’s GPs manage patients, medicines

Comes as doctor groups fear that primary care is struggling under increasing workloads

- PMLiVE

Quality in Care’s 2015 diabetes programme launches at Diabetes UK

Now open for entries to celebrate best practice in NHS diabetes care

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links